Company Description
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally.
It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen’C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio’B, a portable device to transmit a 12-lead ECG.
The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices, including blood pressure, weighing, oxygen saturation level (TelePulse Oximeter), breath exhalation (TeleBreather), and sugar measuring devices; and TelePress, a remote blood pressure monitoring device for personal use.
It offers its telemedicine services and devices to subscribers using electronic and telecommunication technologies.
The company serves physicians, hospitals, health insurance funds, and patients. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center.
The company was incorporated in 1986 and is headquartered in Tel Aviv, Israel.
| Country | Israel |
| Founded | 1987 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 583 |
| CEO | David Arnon |
Contact Details
Address: Ashdar Building, 90 Yigal Alon Street Tel Aviv, 6789130 Israel | |
| Phone | 972 3 561 2212 |
| Website | shl-telemedicine.com |
Stock Details
| Ticker Symbol | SHLT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001166834 |
| CUSIP Number | 78423T200 |
| ISIN Number | US78423T2006 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| David Arnon | Chief Executive Officer |
| Lior Haalman | Chief Financial Officer |
| Bernd Altpeter | Managing Director of SHL Telemedizin Germany |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 3, 2025 | 6-K | Report of foreign issuer |
| Mar 24, 2025 | 6-K | Report of foreign issuer |
| Mar 21, 2025 | 25 | Filing |
| Mar 13, 2025 | EFFECT | Notice of Effectiveness |
| Mar 12, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Mar 11, 2025 | 6-K | Report of foreign issuer |
| Mar 11, 2025 | POS AM | Post-Effective amendments for registration statement |
| Feb 4, 2025 | 6-K | Report of foreign issuer |
| Dec 10, 2024 | 6-K | Report of foreign issuer |
| Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |